Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in tumor microenvironment-targeted nanomedicine delivery approaches to overcome limitations of immune checkpoint blockade-based immunotherapy
Jaehyun Kim, Juhyeong Hong, Jieun Lee, et al.
Journal of Controlled Release (2021) Vol. 332, pp. 109-126
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 31
Dissolvable Self‐Locking Microneedle Patches Integrated with Immunomodulators for Cancer Immunotherapy
Seung‐Hwan Joo, Jaehyun Kim, Juhyeong Hong, et al.
Advanced Materials (2022) Vol. 35, Iss. 10
Open Access | Times Cited: 37
Photothermal-triggered dendrimer nanovaccines boost systemic antitumor immunity
Siyan Shen, Yue Gao, Zhijun Ouyang, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 171-183
Closed Access | Times Cited: 26
Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy
Zhonglei Wang, Liyan Yang
Pharmacological Research (2024) Vol. 203, pp. 107150-107150
Open Access | Times Cited: 9
Application of Nanoparticles in the Treatment of Lung Cancer With Emphasis on Receptors
Jingyue Wang, Tong Zhou, Ying Liu, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 27
Emerging nanomedicines strategies focused on tumor microenvironment against cancer recurrence and metastasis
Yi Feng, Zhen Liao, Hanxi Zhang, et al.
Chemical Engineering Journal (2022) Vol. 452, pp. 139506-139506
Closed Access | Times Cited: 27
Drug-drug conjugates self-assembled nanomedicines triggered photo−/immuno- therapy for synergistic cancer treatments
Haijing Qu, Longmeng Li, Han Chen, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 361-375
Open Access | Times Cited: 16
Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
Xin Zhang, Xuemei Wang, Lijian Hou, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances
Tingrui Zhang, Zongguang Tai, Fengze Miao, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 372-396
Closed Access | Times Cited: 5
Developing a Gallium(III) Agent Based on the Properties of the Tumor Microenvironment and Lactoferrin: Achieving Two-Agent Co-delivery and Multi-targeted Combination Therapy of Cancer
Tongfu Yang, Zhenlei Zhang, Juzheng Zhang, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 793-803
Closed Access | Times Cited: 25
PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases
Ke Zhang, Xiangyi Kong, Yuan Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization
Francesca Rodà, Riccardo Caraffi, Silvia Picciolini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2496-2496
Open Access | Times Cited: 13
Engineering TGF-β inhibitor-encapsulated macrophage-inspired multi-functional nanoparticles for combination cancer immunotherapy
Jae‐Hyun Kim, Minjeong Kim, Seok‐Beom Yong, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 11
Biomimetic Cell-Derived Nanoparticles: Emerging Platforms for Cancer Immunotherapy
Tingting Hu, Yuezhou Huang, Jing Liu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1821-1821
Open Access | Times Cited: 10
In Situ Cocktail Nanovaccine for Cancer Immunotherapy
Mohan Liu, Daoyuan Xie, Die Hu, et al.
Advanced Science (2023) Vol. 10, Iss. 31
Open Access | Times Cited: 10
Polymersomes as a potential platform for cancer immunotherapy
Jari F. Scheerstra, Annelies C. Wauters, Jurjen Tel, et al.
Materials Today Advances (2021) Vol. 13, pp. 100203-100203
Open Access | Times Cited: 25
Polydopamine Nanoformulations Induced ICD and M1 Phenotype Macrophage Polarization for Enhanced TNBC Synergistic Photothermal Immunotherapy
Siqi Geng, Baoru Fang, Ke Wang, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 44, pp. 59814-59832
Closed Access | Times Cited: 2
Nanomedicines for the Efficient Treatment of Intracellular Bacteria: The “ART” Principle
Hongzhao Qi, Peipei Shan, Yin Wang, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 18
Insights into Tumor Microenvironment (TME) and the Nano Approaches to Suppress Tumor Growth
Perpetua Takunda Kutoka, Theodora Amanda Seidu, Vongai Baye, et al.
OpenNano (2022) Vol. 7, pp. 100041-100041
Open Access | Times Cited: 11
Advanced nanovaccines based on engineering nanomaterials for accurately enhanced cancer immunotherapy
Dandan Wang, Wenxing Gu, Weiliang Chen, et al.
Coordination Chemistry Reviews (2022) Vol. 472, pp. 214788-214788
Closed Access | Times Cited: 11
The Application of Nanotechnology in Immunotherapy based Combinations for Cancer Treatment
Hongxia Li, Qiuxia Fu, Tobias Achu Muluh, et al.
Recent Patents on Anti-Cancer Drug Discovery (2022) Vol. 18, Iss. 1, pp. 53-65
Closed Access | Times Cited: 10
Optically Coupled PtOEP and DPA Molecules Encapsulated into PLGA-Nanoparticles for Cancer Bioimaging
Olena Vepris, Christina Eich, Yansong Feng, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1070-1070
Open Access | Times Cited: 10
Progress in non-viral localized delivery of siRNA therapeutics for pulmonary diseases
Jingjing Gao, Ziting Xia, Dilrasbonu Vohidova, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 4, pp. 1400-1428
Open Access | Times Cited: 10
Current development of theragnostic nanoparticles for women’s cancer treatment
Ananya Kashyap, Madhubala Kumari, Arnika Singh, et al.
Biomedical Materials (2024) Vol. 19, Iss. 4, pp. 042001-042001
Closed Access | Times Cited: 1
Membrane Fusion Liposomes Deliver Antifibrotic and Chemotherapeutic Drugs Sequentially to Enhance Tumor Treatment Efficacy by Reshaping Tumor Microenvironment
Nan Jia, Qi Wang, Wenpan Li, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 20
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top